Similar articles

• Summaries for patients: Intravenous immunoglobulin treatment of the complex regional pain syndrome.

  [No authors listed] [No authors listed] Ann Intern Med. 2010 Feb 2;152(3):I48. doi: 10.7326/0003-4819-152-3-201002020-00003. Ann Intern Med. 2010. PMID: 20124227 No abstract available.
• Skepticism about intravenous immunoglobulin treatment in long-standing complex regional pain syndrome.

  Goebel A, Baranowski A, Ghiai A, Maurer K, McCabe C, Ambler G. Goebel A, et al. Ann Intern Med. 2010 Jun 15;152(12):829-30; author reply 830. doi: 10.7326/0003-4819-152-12-201006150-00024. Ann Intern Med. 2010. PMID: 20547920 No abstract available.
• Favorable outcome of an acute complex regional pain syndrome with immunoglobulin infusions.

  Medlin F, Zekeridou A, Renaud S, Kuntzer T. Medlin F, et al. Clin J Pain. 2013 Nov;29(11):e33-4. doi: 10.1097/AJP.0b013e318292189e. Clin J Pain. 2013. PMID: 24104048
• Pharmacotherapy options for complex regional pain syndrome.

  Eisenberg E, Geller R, Brill S. Eisenberg E, et al. Expert Rev Neurother. 2007 May;7(5):521-31. doi: 10.1586/14737175.7.5.521. Expert Rev Neurother. 2007. PMID: 17492902 Review.
• Fibromyalgia and the complex regional pain syndrome: similarities in pathophysiology and treatment.

  Wurtman RJ. Wurtman RJ. Metabolism. 2010 Oct;59 Suppl 1:S37-40. doi: 10.1016/j.metabol.2010.07.008. Metabolism. 2010. PMID: 20837192 Review.